StockData
Telix Pharmaceuticals Ltd logo

Telix Pharmaceuticals Ltd (TLX) stock

TLXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as TLPPF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 20, 2026Score 3/30
$8.86−0.06 (-0.73%)

Close on Nov 17, 2026Market cap $3.00BP/E –Yield –

Telix Pharmaceuticals operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -$17.29M, down 162.9% from the year before.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$17.29M-162.9%
FY2024Dec 31, 2024$27.49M+92.6%
FY2023Dec 31, 2023$14.27M–

More Telix Pharmaceuticals figures

See a number that looks wrong?